Cerity Partners
CCEL icon

Cerity Partners’s Cryo-Cell International CCEL Stock Holding History

Cerity Partners’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,563
Closed -$67.3K – 3270
2025
Q4 		$67.3K Hold
19,563
– – ﹤0.01% 2790
2025
Q3 		$90.8K Hold
19,563
– – ﹤0.01% 2640
2025
Q2 		$102K Hold
19,563
– – ﹤0.01% 2473
2025
Q1 		$125K Hold
19,563
– – ﹤0.01% 2295
2024
Q4 		$145K Hold
19,563
– – ﹤0.01% 2289
2024
Q3 		$125K Hold
19,563
– – ﹤0.01% 2404
2024
Q2 		$149K Hold
19,563
– – ﹤0.01% 2069
2024
Q1 		$146K Hold
19,563
– – ﹤0.01% 2162
2023
Q4 		$112K Hold
19,563
– – ﹤0.01% 1778
2023
Q3 		$103K Hold
19,563
– – ﹤0.01% 1330
2023
Q2 		$119K Hold
19,563
– – ﹤0.01% 1534
2023
Q1 		$59.1K Hold
19,563
– – ﹤0.01% 1799
2022
Q4 		$82.8K Buy
+19,563
New +$93.7K ﹤0.01% 1419

Other funds holding CCEL

SA
SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cerity Partners's CCEL Position: Q1 2026 in Review

Cerity Partners sold out of Cryo-Cell International (CCEL) in Q1 2026, closing a stake of 19,563 shares — an estimated $67.3K sold.

Cerity Partners first reported a position in CCEL in Q4 2022 and held it in 13 quarters. The position peaked at $149K in Q2 2024. 11 funds tracked by Wall St. Rank hold CCEL as of Q1 2026.

  • Cerity Partners reported no remaining Cryo-Cell International position as of Q1 2026 after selling out during the quarter.
  • Cerity Partners sold 19,563 Cryo-Cell International shares in Q1 2026, an estimated $67.3K.
  • Cerity Partners first reported a position in Cryo-Cell International in Q4 2022 and held it in 13 quarters.
  • Cerity Partners's Cryo-Cell International position peaked at $149K in Q2 2024.
  • 11 funds tracked by Wall St. Rank held Cryo-Cell International as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.